A screening method to assess biological effects of microRNA overexpression in Chinese hamster ovary cells

Biotechnology and Bioengineering

Volumn 109, Issue 6, 2012, Pages 1376-1385

  Jadhav, Vaibhav ^a   Hackl, Matthias ^a   Hernandez Bort, Juan A ^a,b   Wieser, Matthias ^b   Harreither, Eva ^a   Kunert, Renate ^a   Borth, Nicole ^a,b   Grillari, Johannes ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

Author keywords

Chinese hamster ovary cells; EngimiR; Functional screening; MicroRNA; MiR 17

Indexed keywords

CHINESE HAMSTER OVARY CELLS; ENGIMIR; FUNCTIONAL SCREENING; MICRORNAS; MIR-17;

CELL CULTURE; CELL PROLIFERATION; CELLS; CLONING; GENES; NUCLEIC ACIDS; PHYSIOLOGY; PRODUCTIVITY; TRANSCRIPTION;

MOLECULAR BIOLOGY;

GREEN FLUORESCENT PROTEIN; MICRORNA; MICRORNA 17; MICRORNA 21; MICRORNA 210; MICRORNA 221; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CELLULAR PARAMETERS; CHINESE HAMSTER; CHO CELL; CLONING; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC SCREENING; GENETIC TRANSFECTION; METHODOLOGY; NONHUMAN; PHENOTYPE;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GENE EXPRESSION REGULATION; GENETIC TESTING; MICRORNAS; RECOMBINATION, GENETIC;

CRICETULUS GRISEUS;

EID: 84859926395     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24490     Document Type: Article

References (64)

1. Ambros V. 2004. The functions of animal microRNAs. Nature 431(7006): 350- 355.
2. Ambros V, Lee RC. 2004. Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol 265: 131- 158.
3. Barron N, Kumar N, Sanchez N, Doolan P, Clarke C, Meleady P, O'Sullivan F, Clynes M. 2011a. Engineering CHO cell growth and recombinant protein productivity by over-expression of miR-7. J Biotechnol 151(2): 204- 211.
4. Barron N, Sanchez N, Kelly P, Clynes M. 2011b. MicroRNAs: Tiny targets for engineering CHO cell phenotypes? Biotechnol Lett 33(1): 11- 21.
5. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116(2): 281- 297.
6. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136(2): 215- 233.
7. Becker J, Hackl M, Rupp O, Jakobi T, Schneider J, Szczepanowski R, Bekel T, Borth N, Goesmann A, Grillari J, Kaltschmidt C, Noll T, Pühler A, Tauch A, Brinkrolf K. 2011. Unraveling the Chinese hamster ovary cell line transcriptome by next-generation sequencing. J Biotechnol 156(3): 227- 235.
8. Bort JAH, Hackl M, Höflmayer H, Jadhav V, Harreither E, Kumar N, Ernst W, Grillari J, Borth N. 2011. Dynamic mRNA and miRNA profiling of CHO-K1 suspension cell cultures. Biotechnol J DOI: 10.1002/biot.201100143
9. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567): 550- 553.
10. Buechner J, Henriksen JR, Haug BH, Tomte E, Flaegstad T, Einvik C. 2011. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells. Differentiation 81(1): 25- 34.
11. Carleton M, Cleary MA, Linsley PS. 2007. MicroRNAs and cell cycle regulation. Cell Cycle 6(17): 2127- 2132.
12. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33(20): e179: 1- 9.
13. Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, Qiao C, Xu J, Li J. 2011. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Cancer Lett 309(1): 62- 70.
14. Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, Vojtek AB, Turner DL. 2006. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR155. Nucleic Acids Res 34(7): e53: 1- 14. DOI: 10.1093/nar/gkl143
15. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM. 2008. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9(8): R127. 1- 14.
16. Codamo J, Munro TP, Hughes BS, Song M, Gray PP. 2011. Enhanced CHO cell-based transient gene expression with the epi-CHO expression system. Mol Biotechnol 48(2): 109- 115.
17. Cohen S. 2010. MicroRNAs in animal development. Editorial. Semin Cell Dev Biol 21(7): 727.
18. Cullen BR. 2004. Transcription and processing of human microRNA precursors. Mol Cell 16(6): 861- 865.
19. DeMaria CT, Cairns V, Schwarz C, Zhang J, Guerin M, Zuena E, Estes S, Karey KP. 2007. Accelerated clone selection for recombinant CHO cells using a FACS-based high-throughput screen. Biotechnol Prog 23(2): 465- 472.
20. Dreesen IA, Fussenegger M. 2011. Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of Chinese hamster ovary cells. Biotechnol Bioeng 108(4): 853- 866.
21. Druz A, Chu C, Majors B, Santuary R, Betenbaugh M, Shiloach J. 2011. A novel microRNA mmu-miR466h affects apoptosis regulation in mammalian cells. Biotechnol Bioeng 108(7): 1651- 1661.
22. Epanchintsev A, Jung P, Menssen A, Hermeking H. 2006. Inducible microRNA expression by an all-in-one episomal vector system. Nucleic Acids Res 34(18): e119. 1- 8.
23. Fatica A, Rosa A, Fazi F, Ballarino M, Morlando M, De Angelis FG, Caffarelli E, Nervi C, Bozzoni I. 2006. MicroRNAs and hematopoietic differentiation. Cold Spring Harb Symp Quant Biol 71: 205- 210.
24. Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ. 2011. MicroRNAs in lipid metabolism. Curr Opin Lipidol 22(2): 86- 92.
25. Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, Valdagni R, Daidone MG, Zaffaroni N. 2010. miR-21: An oncomir on strike in prostate cancer. Mol Cancer 9(12): 1- 12.
26. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1): 92- 105.
27. Gaillet B, Gilbert R, Broussau S, Pilotte A, Malenfant F, Mullick A, Garnier A, Massie B. 2010. High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch. Biotechnol Bioeng 106(2): 203- 215.
28. Gammell P, Barron N, Kumar N, Clynes M. 2007. Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells. J Biotechnol 130(3): 213- 218.
29. Grillari J, Hackl M, Grillari-Voglauer R. 2010. miR-17-92 cluster: Ups and downs in cancer and aging. Biogerontology 11(4): 501- 506.
30. Hackl M, Jakobi T, Blom J, Doppmeier D, Brinkrolf K, Szczepanowski R, Bernhart SH, Siederdissen CH, Bort JA, Wieser M, et al. 2011. Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering. J Biotechnol 153(1-2): 62- 75.
31. Jayapal KR, Wlaschin KF, Hu WS, Yap MGS. 2007. Recombinant protein therapeutics from CHO cells 20 years and counting. Chem Eng Prog 103(10): 40- 47.
32. Krutzfeldt J, Stoffel M. 2006. MicroRNAs: A new class of regulatory genes affecting metabolism. Cell Metab 4(1): 9- 12.
33. Kuhnert F, Kuo CJ. 2010. miR-17-92 angiogenesis micromanagement. Blood 115(23): 4631- 4633.
34. Lattenmayer C, Loeschel M, Schriebl K, Steinfellner W, Sterovsky T, Trummer E, Vorauer-Uhl K, Muller D, Katinger H, Kunert R. 2007. Protein-free transfection of CHO host cells with an IgGfusion protein: Selection and characterization of stable high producers and comparison to conventionally transfected clones. Biotechnol Bioeng 96(6): 1118- 1126.
35. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA, Farace MG, Agami R. 2007. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR222 promotes cancer cell proliferation. EMBO J 26(15): 3699- 3708.
36. Lim SF, Chuan KH, Liu S, Loh SO, Chung BY, Ong CC, Song Z. 2006. RNAi suppression of Bax and Bak enhances viability in fed-batch cultures of CHO cells. Metab Eng 8(6): 509- 522.
37. Lin N, Davis A, Bahr S, Borgschulte T, Achtien K, Kayser K. 2011. Profiling highly conserved microrna expression in recombinant IgG-producing and parental chinese hamster ovary cells. Biotechnol Prog 27(4): 1163- 1171.
38. Lindow M. 2011. Prediction of targets for microRNAs. Methods Mol Biol 703: 311- 317.
39. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. 2009. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104(4): 476- 487.
40. Muller D, Katinger H, Grillari J. 2008. MicroRNAs as targets for engineering of CHO cell factories. Trends Biotechnol 26(7): 359- 365.
41. Olive V, Jiang I, He L. 2010. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42(8): 1348- 1354.
42. Omasa T, Onitsuka M, Kim WD. 2010. Cell engineering and cultivation of chinese hamster ovary (CHO) cells. Curr Pharm Biotechnol 11(3): 233- 240.
43. Pickering MT, Stadler BM, Kowalik TF. 2009. miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 28(1): 140- 145.
44. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. 2010. miR-221 over-expression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 107(1): 264- 269.
45. Puisségur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K, Cardinaud B, Hofman V, Fourre S, Magnone V, Ricci JE, Pouysségur J, Gounon P, Hofman P, Barbry P, Mari B. 2011. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 18(3): 465- 478.
46. Sayed D, Abdellatif M. 2011. MicroRNAs in development and disease. Physiol Rev 91(3): 827- 887.
47. Shah MY, Calin GA. 2011. MicroRNAs miR-221 and miR-222: A new level of regulation in aggressive breast cancer. Genome Med 3(8): 56.
48. Shan ZX, Lin QX, Deng CY, Zhou ZL, Tan HH, Fu YH, Li XH, Zhu JN, Mai LP, Kuang SJ, Lin SG, Yu XY. 2010. Comparison of approaches for efficient gene silencing induced by microRNA-based short hairpin RNA and indicator gene expression. Mol Biol Rep 37(4): 1831- 1839.
49. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. 2007. miR-21-mediated tumor growth. Oncogene 26(19): 2799- 2803.
50. Subramanian S, Steer CJ. 2010. MicroRNAs as gatekeepers of apoptosis. J Cell Physiol 223(2): 289- 298.
51. Subramanyam D, Blelloch R. 2011. From microRNAs to targets: Pathway discovery in cell fate transitions. Curr Opin Genet Dev 21(4): 498- 503.
52. van Haaften G, Agami R. 2010. Tumorigenicity of the miR-17-92 cluster distilled. Genes Dev 24(1): 1- 4.
53. Walsh G. 2010. Biopharmaceutical benchmarks 2010. Nat Biotechnol 28(9): 917- 924.
54. Wang ZZ, Xu NZ. 2011. MiR-17-92 in cancer. Sheng Li Ke Xue Jin Zhan 42(2): 91- 94.
55. Wang F, Yang F, Zhang L, Sun S. 2010a. Is increasing the copy number of the microRNA precursor in a vector really helpful for further improving the level of mature microRNA in stable cells? Hepatology 52(4): 1517.
56. Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C, Quan L, Bai J, Xu N. 2010b. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level. Int J Oncol 37(5): 1315.
57. Wang X, Han L, Zhang A, Wang G, Jia Z, Yang Y, Yue X, Pu P, Shen C, Kang C. 2011. Adenovirusmediated shRNAs for co-repression of miR-221 and miR-222 expression and function in glioblastoma cells. Oncol Rep 25(1): 97- 9105.
58. Wong P, Iwasaki M, Somervaille TC, Ficara F, Carico C, Arnold C, Chen CZ, Cleary ML. 2010. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res 70(9): 3833- 3842.
59. Woods K, Thomson JM, Hammond SM. 2007. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 26(282): 2130- 2134.
60. Xing ZZ, Kenty B, Koyrakh I, Borys M, Pan SH, Li ZJ. 2011. Optimizing amino acid composition of CHO cell culture media for a fusion protein production. Process Biochem 46(7): 1423- 1429.
61. Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, Chen W, Xie M, Wang W, Hammond S, Andersen MR, Neff N, Passarelli B, Koh W, Fan HC, Wang J, Gui Y, Lee KH, Betenbaugh MJ, Quake SR, Famili I, Palsson BO, Wang J. 2011. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 29(8): 735- 741.
62. Yang RF, Chen LJ, Li JY. 2010. mir-17-92 cluster and tumor. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(5): 1341- 1344.
63. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, Hyslop T, McCue P, Pestell RG. 2008. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182(3): 509- 517.
64. Zhou M, Crawford Y, Ng D, Tung J, Pynn AF, Meier A, Yuk IH, Vijayasankaran N, Leach K, Joly J, Snedecor B, Shen A. 2011. Decreasing lactate level and increasing antibody production in Chinese hamster ovary cells (CHO) by reducing the expression of lactate dehydrogenase and pyruvate dehydrogenase kinases. J Biotechnol 153(1-2): 27- 34.